We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watchdog Groups Say It’s Time to Fix FDA’s Accelerated Approval Pathway
Watchdog Groups Say It’s Time to Fix FDA’s Accelerated Approval Pathway
In the wake of the FDA’s controversial Aduhelm approval, public and private groups are calling on the agency to amend its accelerated approval pathway, including forcing companies to complete the required confirmatory studies in a timely manner and getting rid of drugs that fail the postmarket test.